Shu-Lin Liu

Over 15 years of experience in vivo studies, including viral and non-viral gene therapy, small molecular drug discovery, and therapeutic recombinant protein application in different disease fields such as cardiovascular disease, autoimmune disease, hearing and inner ear disorder, and lung inflammation.